The president and CEO of Southern Research Institute has been named president of the Controlled Release Society.
Southern Research Institute announced that Arthur J. Tipton, president and CEO of Southern Research Institute, has been named president of the Controlled Release Society (CRS) for the 2014-2015 term. The inauguration took place at the Society's annual meeting on July 12 in Chicago with attendees from more than 40 countries.
The Controlled Release Society is an international, interdisciplinary, not-for-profit organization whose guiding purpose is the advancement of delivery science and technology.
Tipton has worked in the pharmaceutical and biotechnology industries for more than 25 years and has pioneered the use of controlled release technologies through his work in polymer science and engineering, according to a Southern Research Institute.
"It is an honor to be named president of the Controlled Release Society," said Tipton in a statement. "Over the past several decades, controlled-release formulations have changed the treatment paradigm for a number of serious health conditions, including cancer, pain management, cardiovascular and central nervous system disorders, and have been involved in many industrial applications such as food flavorings and long acting fertilizers. As controlled release technologies continue to mature, industry and academia are meeting the challenges of developing the next generation of faster, safer, more accessible formulations, and CRS represents the world's leaders in advancing these novel techniques. I look forward to leading this distinguished and important group."
Previously Tipton held senior positions at Durect Corporation, its wholly-owned subsidiary Southern BioSystems, Birmingham Polymers, and Atrix Laboratories. In 2005, he founded Brookwood Pharmaceuticals, which was subsequently acquired by SurModics and later by Evonik. At Evonik, he served as senior vice president of the Birmingham Division and also led the company's global drug delivery program. Tipton has 31 issued U.S. patents, 22 published U.S. patent applications, and numerous foreign equivalents, with more than 70 presentations and publications.
Tipton earned a doctorate in polymer science and engineering from the University of Massachusetts in Amherst, and a bachelor of science degree in chemistry from Spring Hill College.
Source: Southern Research Institute
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.